Cost effectiveness of pharmaceutical interventions in postmenopausal women: A comparison of raloxifene, hormone replacement therapy, and alendronate.

被引：0
|
作者：
Tosteson, ANA
Van Orden, LS
Minshall, ME
Grove, M
Moncur, M
Kneeland, TS
Muchmore, DB
机构：
[1] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA
[2] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1999年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SA360
引用
收藏
页码：S398 / S398
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of raloxifene and hormone replacement therapy in postmenopausal women
    Chen, TM
    Armstrong, K
    Albert, D
    Hrung, J
    Schwartz, JS
    [J]. MEDICAL DECISION MAKING, 1998, 18 (04) : 477 - 477
  • [2] Cost-effectiveness analysis of raloxifene and hormone replacement therapy in postmenopausal women.
    Chen, TM
    Armstrong, K
    Albert, D
    Hrung, J
    Schwartz, JS
    [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S45 - S45
  • [3] Cost-effectiveness of osteoporosis screening and treatment with hormone replacement therapy, raloxifene, or alendronate
    Mobley, LR
    Hoerger, TJ
    Wittenborn, JS
    Galuska, DA
    Rao, JK
    [J]. MEDICAL DECISION MAKING, 2006, 26 (02) : 194 - 206
  • [4] Cost-effectiveness of raloxifene and hormone replacement therapy in postmenopausal women: Impact of breast cancer risk
    Armstrong, K
    Chen, TM
    Albert, D
    Randall, RC
    Schwartz, JS
    [J]. OBSTETRICS AND GYNECOLOGY, 2001, 98 (06): : 996 - 1003
  • [5] Cost effectiveness of hormone replacement therapy in French postmenopausal women
    PluBureau, G
    Bureau, D
    Thalabard, JC
    [J]. HORMONAL CARCINOGENESIS II, 1996, : 383 - 385
  • [6] Individualizing therapy to prevent postmenopausal osteoporosis: A comparison of hormone therapy, alendronate, and raloxifene
    Col, NF
    Pauker, SG
    Goldberg, RJ
    Eckman, MH
    Orr, RK
    Ross, EM
    Wong, JB
    [J]. MEDICAL DECISION MAKING, 1998, 18 (04) : 467 - 467
  • [7] Comparison of alendronate and raloxifene in postmenopausal women with osteoporosis
    Sanad, Z.
    Ellakwa, H.
    Desouky, B.
    [J]. CLIMACTERIC, 2011, 14 (03) : 369 - 377
  • [8] Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women
    Schousboe, JT
    Nyman, JA
    Kane, RL
    Ensrud, KE
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (09) : 734 - 741
  • [9] Uterine effects of raloxifene in comparison with continuous-combined hormone replacement therapy in postmenopausal women
    Fugère, P
    Scheele, WH
    Shah, A
    Strack, TR
    Glant, MD
    Jolly, E
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 182 (03) : 568 - 574
  • [10] Effects of raloxifene and hormone replacement therapy on markers of inflammation in healthy postmenopausal women
    Cox, DA
    Sashegyi, A
    Paul, S
    Dean, RA
    Tracy, RP
    Walsh, BW
    Anderson, PW
    [J]. OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S207 - S207
12345